HomeGENX • CVE
add
Genix Pharmaceuticals Corp
Previous close
$0.030
Day range
$0.035 - $0.035
Year range
$0.025 - $0.090
Market cap
2.07M CAD
Avg Volume
5.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.60K | -24.30% |
Net income | -107.25K | -81.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -30.32K | 24.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.18K | -65.77% |
Total assets | 56.49K | -77.10% |
Total liabilities | 1.35M | -6.66% |
Total equity | -1.29M | — |
Shares outstanding | 59.22M | — |
Price to book | -1.50 | — |
Return on assets | -149.96% | — |
Return on capital | 20.41% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -107.25K | -81.61% |
Cash from operations | -63.10K | -48.25% |
Cash from investing | — | — |
Cash from financing | 54.80K | 36.23% |
Net change in cash | -8.30K | -255.53% |
Free cash flow | -37.40K | 20.67% |
About
Founded
1993
Headquarters
Website
